No one knows for sure what the new year will hold for the market. However, some stocks' chances for success look particularly good.
Novo Nordisk (NYSE: NVO) and AstraZeneca (NASDAQ: AZN) are among the largest companies in the pharmaceutical industry. Both have generally produced strong financial results in 2024, but one wouldn't know...
Pfizer’s PFE stock has risen 5.6% in the past month. This was due to the company’s encouraging guidance for 2025 issued in mid-December 2025. Pfizer also maintained its previously issued financial...
Elon Musk’s preference for Eli Lilly’s Mounjaro over Novo Nordisk’s Ozempic has sparked increased interest in weight-loss drug stocks.
Here are four stocks to buy now that could offer investors upside in the short and long terms.
Shares of Novo Nordisk are in free fall following lackluster results from a new clinical trial.
Stocks soared in 2024, and 2025 could be even stronger. Let's look at key trends, government policies, and sectors poised for growth in the year ahead.
Eli Lilly is very close to joining the $1 trillion club. Should you buy shares now?
J&J’s JNJ stock closed at $145.05 on Friday, quite close to its 52-week low of $142.75. In the past three months, J&J’s stock has lost more than 10%.Slowing sales of J&J’s MedTech segment, the upcoming...
Stocks splits have been a huge market theme in 2024, with big names across industries, from technology giant Nvidia to consumer stock Walmart completing such operations. Companies often launch this move...